We are currently recruiting participants for the following studies:

Schizophrenia - A trial of add-on sulforaphane nutraceutical to reduce symptoms of schizophrenia

This study is seeking volunteers for a clinical trial that may reduce symptoms of schizophrenia. 

Participants take add-on sulforaphane or placebo for eighteen weeks and are compensated for their time. 

Sulforaphane is a molecule found naturally in broccoli and other cruciferous plants; it has anti-inflammatory properties and has been shown to have health benefits. We are conducting this trial to determine if it may be helpful for persons with schizophrenia who have ongoing symptoms.

Eligibility:

  • 18 - 65 years old
  • Diagnosed with schizophrenia or schizoaffective disorder 

PI: Faith Dickerson, PhD, MPH

Funding source: Stanley Medical Research Institute

To participate, email Cassie Stallings, R.N.C., or call 410-938-4356.

Learn more about this study.


Bipolar Depression - A trial of an add-on probiotic to prevent relapse and improve the clinical course after hospitalization for bipolar depression

This study is seeking volunteers for a clinical trial that may help prevent readmission for an exacerbation of psychiatric symptoms. Participants take add-on probiotics or placebo for 24 weeks and are compensated for their time. 

Probiotic supplements contain tiny healthy organisms similar to those found in breast milk, yogurt, and some other foods. They are thought to provide health benefits by improving digestion and modulating the immune response.  

Eligibility:

  • Are currently or recently admitted to an inpatient or day hospital program for symptoms of bipolar depression, and with a diagnosis of Bipolar I or II disorder
  • 18 - 65 years old
  • Available for follow-up phone calls weekly and in-person visits every four weeks at Sheppard Pratt's Towson campus during a 24-week treatment period

PI: Faith Dickerson, PhD, MPH

Founding source: Stanley Medical Research Institute

To participate, email Cassie Stallings, R.N.C., or call 410-938-4356.

Learn more about this study.


Bipolar Disorder - Transcranial Magnetic Stimulation

This study is an Open-Label study of Transcranial Magnetic Stimulation (TMS) in patients with Bipolar Disorder who are currently depressed.

We are currently seeking participants ages 18 and older to enroll in this outpatient study.

PI: Scott Aaronson, M.D.

Sponsor: Sheppard Pratt Health System

To participate in this study, email Brittany Troen or call 410-938-3139.

Learn more about this study.


Major Depressive Disorder - Brexpiprazole as adjunctive therapy

This study will assess the safety, efficacy and tolerability of brexpiprazole as adjunctive therapy to protocol-specific open-label antidepressant therapy.

We are currently seeking participants ages 18 to 65 to enroll in this outpatient study.

PI: Scott Aaronson, M.D.

Sponsor: Sheppard Pratt Health System/Otsuka Pharmaceutical Development & Commercialization, Inc.

To participate in this study, email Brittany Troen or call 410-938-3139.

Learn more about this study.